Under the theme of “Emerging Targets, Novel Candidates and Innovative Strategies”, this three-day international meeting will bring together medicinal chemists and related scientists in order to share exciting new results and first-time disclosures in various areas of drug discovery and development, including cancer, infectious diseases, CNS, inflammation, pain and metabolic disease. Twenty-three internationally recognized plenary speakers will present lectures with a focus on emerging targets, novel drug candidates and new strategies and technologies. Furthermore, poster sessions will help to strengthen ties between scientists in an environment that will foster interaction and discussion.

Organising Committee:
David Andreu (Universitat Pompeu Fabra, Spain & SEQT)
Mark E. Bunnage (Pfizer, UK, EFMC)
José Luis Díaz (Almirall, Spain & SEQT)
Gerhard Ecker (University of Vienna, Austria & EFMC)
Javier Fernández-Gadea (Janssen-Cilag, Spain, EFMC & SEQT)
Giovanni Gaviraghi (Siena Biotech, Italy)
María L. López-Rodríguez (Universidad Complutense de Madrid, Spain & SEQT)
Alfredo Martín (Lilly, Spain & SEQT)
Roberto Pellicciari (University of Perugia, Italy & EFMC)
Ferran Sanz (Universitat Pompeu Fabra, Spain & SEQT)
Antoni Torrens (Esteve, Spain & SEQT)

Contact person: M.L. López-Rodriguez
Tel: +34-91-3944-239
Fax: +34-91-3944-103
Email: mluzlr@quim.ucm.es

The Meeting is co-organized by the European Federation for Medicinal Chemistry, the Division of Medicinal Chemistry of ACS and the Swedish Academy of Pharmaceutical Sciences. It will bring together speakers from Scandinavia/Europe and USA that will share exciting new results and first time disclosures in several areas of drug discovery.

Topics will include

• ADME Profiling
• Cancer and Epigenetics
• Case Studies and Emerging Targets
• Chemical Neuroscience
• GPCR´s
• Protein-Protein Interactions
• Structure Based Ligand Design